Not all people with Merkel cell carcinoma are cured with standard therapy. As a result, many patients seek help through clinical trials, which are research studies designed to develop better treatments. Patients participating in clinical trials have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about the disease.
For more information about clinical studies, see the Patient Guide to Clinical Trials which includes Myths vs Facts.
Read more about other research at Dr. Nghiem’s Lab or look at the trials for Merkel cell carcinoma that are currently recruiting patients at SCCA.